Cargando…
Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview
The human T cell leukemic/lymphotropic virus type 1 (HTLV-1), discovered several years ago, is the causative agent for a rapid progressive haematological malignancy, adult T cell leukemia (ATL), for debilitating neurological diseases and for a number of inflammatory based diseases. Although the hete...
Autores principales: | Marino-Merlo, Francesca, Balestrieri, Emanuela, Matteucci, Claudia, Mastino, Antonio, Grelli, Sandro, Macchi, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281255/ https://www.ncbi.nlm.nih.gov/pubmed/32369988 http://dx.doi.org/10.3390/pathogens9050342 |
Ejemplares similares
-
Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells
por: Matteucci, Claudia, et al.
Publicado: (2020) -
Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
por: Macchi, Beatrice, et al.
Publicado: (2011) -
NF-κB-Dependent Production of ROS and Restriction of HSV-1 Infection in U937 Monocytic Cells
por: Marino-Merlo, Francesca, et al.
Publicado: (2019) -
Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma
por: Marino-Merlo, Francesca, et al.
Publicado: (2018) -
Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients
por: Macchi, Beatrice, et al.
Publicado: (2020)